Search research articles
Contact Us
Filters
Showing results (1-10 of 113) with videos related to
Page
of 12
Sort By:
The American Journal of Cardiology
|
July 28, 2004
Safety and compliance with once-daily niacin extended-release/lovastatin as initial therapy in the Impact of Medical Subspecialty on Patient Compliance to Treatment (IMPACT) study
Melvyn Rubenfire,
Best Practice & Research. Clinical Endocrinology & Metabolism
|
May 21, 2014
Best Practice & Research Clinical Endocrinology & Metabolism. Pharmacological treatment of dyslipidaemias. Preface
Melvyn Rubenfire
Clinical Cardiology
|
April 7, 2006
Life-threatening acute and chronic thromboembolic pulmonary hypertension and subclavian vein thrombosis
Mark A Meier, Melvyn Rubenfire
Current Cardiology Reports
|
February 20, 2013
HDL cholesterol and cardiovascular outcomes: what is the evidence?
Melvyn Rubenfire, Robert D Brook
JAMA
|
July 12, 2012
Lipid parameters and cardiovascular events in patients taking statins
Robert D Brook, Melvyn Rubenfire
The Physician and Sportsmedicine
|
December 21, 2017
Cardiovascular Complications of Recreational Physical Activity
Lauren Vander, Barry Franklin, Melvyn Rubenfire
Preventive Cardiology
|
October 1, 2010
Will increasing referral to cardiac rehabilitation improve participation?
Thomas Boyden, Melvyn Rubenfire, Barry Franklin
The Journal of Laboratory and Clinical Medicine
|
April 11, 2002
Antioxidant nutrient supplementation and brachial reactivity in patients with coronary artery disease
Ronald McKechnie, Melvyn Rubenfire, Lori Mosca
The American Journal of Cardiology
|
June 5, 2012
Secondary causes of dyslipidemia
Deepthi Vodnala, Melvyn Rubenfire, Robert D Brook
Critical Care Clinics
|
October 30, 2007
Pulmonary hypertension in the critical care setting: classification, pathophysiology, diagnosis, and management
Melvyn Rubenfire, Melike Bayram, Zachary Hector-Word
Page
of 12
Search research articles
Search
Showing results (1-10 of 113) with videos related to
Sort By:
Page
of 12
The American Journal of Cardiology
|
July 28, 2004
Safety and compliance with once-daily niacin extended-release/lovastatin as initial therapy in the Impact of Medical Subspecialty on Patient Compliance to Treatment (IMPACT) study
Melvyn Rubenfire,
Best Practice & Research. Clinical Endocrinology & Metabolism
|
May 21, 2014
Best Practice & Research Clinical Endocrinology & Metabolism. Pharmacological treatment of dyslipidaemias. Preface
Melvyn Rubenfire
Clinical Cardiology
|
April 7, 2006
Life-threatening acute and chronic thromboembolic pulmonary hypertension and subclavian vein thrombosis
Mark A Meier, Melvyn Rubenfire
Current Cardiology Reports
|
February 20, 2013
HDL cholesterol and cardiovascular outcomes: what is the evidence?
Melvyn Rubenfire, Robert D Brook
JAMA
|
July 12, 2012
Lipid parameters and cardiovascular events in patients taking statins
Robert D Brook, Melvyn Rubenfire
The Physician and Sportsmedicine
|
December 21, 2017
Cardiovascular Complications of Recreational Physical Activity
Lauren Vander, Barry Franklin, Melvyn Rubenfire
Preventive Cardiology
|
October 1, 2010
Will increasing referral to cardiac rehabilitation improve participation?
Thomas Boyden, Melvyn Rubenfire, Barry Franklin
The Journal of Laboratory and Clinical Medicine
|
April 11, 2002
Antioxidant nutrient supplementation and brachial reactivity in patients with coronary artery disease
Ronald McKechnie, Melvyn Rubenfire, Lori Mosca
The American Journal of Cardiology
|
June 5, 2012
Secondary causes of dyslipidemia
Deepthi Vodnala, Melvyn Rubenfire, Robert D Brook
Critical Care Clinics
|
October 30, 2007
Pulmonary hypertension in the critical care setting: classification, pathophysiology, diagnosis, and management
Melvyn Rubenfire, Melike Bayram, Zachary Hector-Word
Page
of 12